grade
pharmaceutical primary standard
API family
orlistat
form
crystalline
manufacturer/tradename
USP
mp
150-157 °C (lit.)
application(s)
USP Biologics
pharmaceutical (small molecule)
format
neat
SMILES string
O=P(c1ccccc1)(c2ccccc2)c3ccccc3
InChI
1S/C18H15OP/c19-20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h1-15H
InChI key
FIQMHBFVRAXMOP-UHFFFAOYSA-N
General description
Orlistat Related Compound C is a chemical impurity related to the active pharmaceutical ingredient Orlistat. It is a by-product that can be formed during the synthesis of Orlistat and is closely monitored in biologic formulations. The presence of this compound is typically controlled, as it may impact the safety, efficacy, and regulatory compliance of the final product.
The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.
Application
- Latanoprost
- Orlistat
Analysis Note
Other Notes
Still not finding the right product?
Explore all of our products under 三苯基氧膦
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 3
存储类别
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 1478833-25MG | 04061833020401 |